The US Federal Trade Commission has disputed more than 300 “bogus” patent listings filed for 20 brand name drugs, including Novo Nordisk’s blockbuster type two diabetes drug Ozempic ...
S ince President Joe Biden appointed Lina Khan as chair of the Federal Trade Commission (FTC) nearly three years ago, her ...
Some courts have deferred to the government in matters of national security, while others have expressed skepticism when it's invoked to suppress speech.
Equity markets appeared to disregard the potential risks associated with antitrust lawsuits targeting some of the largest ...
Welcome to your monthly legal insights on the trends impacting the Retail, Hospitality, and Food & Beverage Industries. Clothing retailer, Express Inc. is the latest major company to file for Chapter ...
according to the FTC. The patents are registered with the Food and Drug Administration, which reviews and approves new drugs. The patent challenges are part of a strategy by President Joe Biden to ...
The FTC also notified the Food and Drug Administration about the challenges. The FDA manages patent listings for approved drugs on a document called the Orange Book. The FTC first challenged ...
The FTC also notified the Food and Drug Administration about the challenges. The FDA manages patent listings for approved drugs on a document called the Orange Book. The FTC first challenged ...
The FTC also notified the Food and Drug Administration about the challenges. The FDA manages patent listings for approved drugs on a document called the Orange Book. The FTC first challenged ...
The FTC also notified the Food and Drug Administration about the challenges. The FDA manages patent listings for approved drugs on a document called the Orange Book. The FTC first challenged ...
The FTC also notified the Food and Drug Administration about the challenges. The FDA manages patent listings for approved drugs on a document called the Orange Book. The FTC first challenged ...
The FTC also notified the Food and Drug Administration about the challenges. The FDA manages patent listings for approved drugs on a document called the Orange Book. The FTC first challenged ...